Investing.com - Yield10 Bioscience (NASDAQ: YTEN) reported first quarter EPS of $-0.760, $0.12 worse than the analyst estimate of $-0.640. Revenue for the quarter came in at $60K versus the consensus estimate of $112.5K.
Yield10 Bioscience's stock price closed at $3.190. It is down -11.140% in the last 3 months and up 44.340% in the last 12 months.
Yield10 Bioscience saw 0 positive EPS revisions and 1 negative EPS revisions in the last 90 days. See Yield10 Bioscience's stock price’s past reactions to earnings here.
According to InvestingPro, Yield10 Bioscience's Financial Health score is "weak performance".
Check out Yield10 Bioscience's recent earnings performance, and Yield10 Bioscience's financials here.
Stay up-to-date on all of the upcoming earnings reports by visiting Investing.com's earnings calendar